TAVI: FDA adds 'valve-in-valve' indication for Medtronic's CoreValve

The FDA approves the use of Medtronic's CoreValve transcatheter aortic valve implant in so-called 'valve-in-valve' replacement procedures.

Food & Drug Administration (FDA), Medtronic

News Well, Pre-Market Approval (PMA), Regulatory/Compliance, Replacement Heart Valves

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/19rSdUy